Felsher B F, Norris M E, Shih J C
N Engl J Med. 1978 Nov 16;299(20):1095-8. doi: 10.1056/NEJM197811162992002.
To test the diagnostic specificity of reduced red-cell uroporphyrinogen decarboxylase activity for porphyria cutanea tarda, we measured enzymic activity in 29 normal subjects and 65 patients with various forms of porphyria. Only patients with porphyria cutanea tarda had subnormal enzymic activity. Patients with acute intermittent porphyria, erythropoietic protoporphyria, variegate porphyria and hereditary coproporphyria had normal or slightly elevated activities. The enzymic activity in normal persons and patients with porphyria cutanea tarda did not differ according to sex. Reduction of iron stores did not alter the enzymic activity in porphyria cutanea tarda. We conclude that reduced red-cell uroporphyrinogen decarboxylase activity is a specific and intrinsic defect in porphyria cutanea tarda; measurement of this enzyme is a reliable diagnostic test for this disease.
为了测试红细胞尿卟啉原脱羧酶活性降低对迟发性皮肤卟啉症的诊断特异性,我们检测了29名正常人和65名患有各种卟啉症的患者的酶活性。只有迟发性皮肤卟啉症患者的酶活性低于正常水平。急性间歇性卟啉症、红细胞生成性原卟啉症、混合型卟啉症和遗传性粪卟啉症患者的酶活性正常或略有升高。正常人和迟发性皮肤卟啉症患者的酶活性在性别上没有差异。铁储备的减少并没有改变迟发性皮肤卟啉症患者的酶活性。我们得出结论,红细胞尿卟啉原脱羧酶活性降低是迟发性皮肤卟啉症的一种特异性内在缺陷;检测这种酶是诊断该疾病的可靠方法。